Amyris Continues to Expand Sales of Squalane in Asia
Amyris Selects Dowell as Squalane Distributor in Korea to Meet Growing Demand
for Best-in-Class Emollient
EMERYVILLE, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Amyris (Nasdaq:AMRS), a
leading renewable products company, announced today the selection of Dowell
C&I Co., Ltd., a supplier of ingredients for the personal care industry, as
its exclusive distributor of Neossance™ Squalane in the Republic of Korea.
"We continue to see strong demand for our Neossance Squalane sales as more
customers recognize the advantages offered by our high-purity, renewable
emollient. This partnership with Dowell expands our network of distributors in
Asia, allowing South Korean formulators access to a stable supply of squalane
produced from sustainable raw materials, and supports our plans to double
squalane sales in 2014," said Zanna McFerson, Chief Business Officer of
"Dowell is a growing Korean distributor of squalane, a best-in-class
emollient. Until recently, squalane could only be sourced from shark liver or
olive oil. Thanks to its breakthrough technology, Amyris produces sugar-based
squalane with excellent performance characteristics," said Jae Cheon You,
President of Dowell.
Squalane is one of the highest quality emollients on the market due to its
sensorial profile, biocompatibility and consistently robust composition. It is
naturally present in the skin lipid barrier, preventing moisture loss while
restoring skin's suppleness and flexibility. Its exceptional moisturizing
properties and ability to penetrate the skin have long made Squalane a
favorite of cosmetics and personal care formulators.
Amyris has developed a unique process that enables the scalable and
sustainable production of Neossance Squalane as a high-purity, high-quality
replacement for traditional shark and olive-based squalane. Neossance Squalane
offers exceptional hydration, biocompatibility, and elegant texture. Amyris's
manufacturing process provides consistent product quality, yielding a
colorless and odorless squalane.
Neossance Squalane is distributed in North America by CenterChem, in Europe by
Laserson (now part of Safic-Alcan), in Japan by Nikko, and in Korea by Dowell.
Amyris will be participating at In-Cosmetics, the leading trade show for the
personal care ingredients industry taking place in April in Hamburg.
About Amyris, Inc.
Amyris is an integrated renewable products company focused on providing
sustainable alternatives to a broad range of petroleum-sourced products.
Amyris uses its industrial synthetic biology platform to convert plant sugars
into a variety of molecules -- flexible building blocks that can be used in a
wide range of products. Amyris is commercializing these products both as No
Compromise® renewable ingredients in cosmetics, flavors and fragrances,
polymers, lubricants and consumer products, and also as No Compromise
renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris,
oversees the establishment and expansion of Amyris's production in Brazil.
More information about Amyris is available atwww.amyris.com.
Dowell C&I is a Korean supplier of high-end ingredients for the health, beauty
and other personal care industries in Asia. Dowell is a rapidly growing player
in the distribution and marketing of products. Its expansion has been centered
on building long-term partnerships with industry leaders in their markets.
Amyris Forward-Looking Statements
This release contains forward-looking statements, and any statements other
than statements of historical facts could be deemed to be forward-looking
statements. These forward-looking statements include, among other things,
statements regarding future events, such as continued market and sales growth
and the benefits of and demand for Neossance Squalane, that involve risks and
uncertainties. These statements are based on management's current expectations
and actual results and future events may differ materially due to risks and
uncertainties, including those associated with any delays or failures in
development, production or commercialization of products, liquidity and
ability to fund capital expenditures, Amyris's reliance on third parties to
achieve its goals, and other risks detailed in the "Risk Factors" section of
Amyris's quarterly report on Form 10-Q filed on November 5, 2013. Amyris
disclaims any obligation to update information contained in these
forward-looking statements whether as a result of new information, future
events, or otherwise.
Amyris, the Amyris logo, Biofene, Neossance and No Compromise are trademarks
or registered trademarks of Amyris, Inc.
CONTACT: Media & Investor Relations
+1 (510) 597-5577
Press spacebar to pause and continue. Press esc to stop.